Earn up to 20 CE creditsClinicians can earn up to 20 CE credits. Learn more about accreditation
Get volume discounts if you are getting 3 or more clinicians certified
Book a Call

Physicians, nurse practitioners, and physician assistants can prescribe peptides in every state, under the same authority that covers any prescription drug. What varies by state is the agreement an NP or PA needs. Here is who can prescribe, who cannot, and a sourced 50-state table of NP practice authority.

Peptides can be prescribed by any clinician whose license includes authority to prescribe drugs: physicians (MD and DO) in every state, and nurse practitioners and physician assistants in every state within their state's scope of practice rules. No peptide-specific license or certification exists, so the question of who can prescribe peptides is answered by the same law that decides who can prescribe any other prescription drug.
That law is mostly state law. Federal compounding law defers to it directly: a 503A pharmacy may compound a drug on the prescription of "a licensed physician or other licensed practitioner authorized by State law to prescribe drugs" (21 U.S.C. 353a). So a physician's authority is the same everywhere, while a nurse practitioner's depends on where the patient is. This guide covers each profession, the 50-state picture for NPs, the one federal rule that singles out physicians, and the checks to run before writing the first prescription.
Status as of October 8, 2026. State classifications below follow the American Association of Nurse Practitioners' 2026 State Practice Environment map (May 2026) and its state fact sheets, with Wisconsin's September 1, 2026 law change added. For whether a given peptide is lawful to prescribe at all, start with our US guide to peptide legality.
| Profession | Can prescribe peptides? | What governs it |
|---|
| Physician (MD or DO) | Yes, in every state | Medical license and the standard of care |
| Nurse practitioner | Yes, in every state | State scope of practice. 27 states and DC allow full practice, often after a transition period; the rest require a physician agreement |
| Physician assistant | Yes, in every state and DC | A supervision, collaboration, or practice agreement with a physician in every state |
| Certified nurse midwife, CRNA | Within their specialty scope | State APRN law |
| Dentist, podiatrist | Within their field of practice | State dental and podiatry acts |
| Naturopathic doctor | In some licensing states, within a formulary | State naturopathic practice acts, which vary widely |
| Pharmacist | Dispenses and compounds on a prescription; originates one only under a state protocol that covers the drug | State pharmacy law |
| Registered nurse | No. May administer on a prescriber's order | State nurse practice act |
| Chiropractor | No, outside New Mexico's advanced practice formulary | State chiropractic act |
| Medical assistant, esthetician, health coach | No | Not licensed to prescribe |
The rest of this guide takes these in order.
Yes. A licensed physician may prescribe an FDA-approved peptide drug for its labeled indication or off label, and may order a compounded peptide when the bulk substance and the pharmacy qualify under federal and state law. Physician prescribing authority is set by the state medical license, and it does not vary by specialty.
Three things limit a physician: the product, the standard of care, and the license's geography.
The product has to have a lawful pathway, since a physician's authority stops at the edge of the drug laws. Doctors cannot lawfully prescribe research grade peptides, the vials sold online as "research use only," because those products are unapproved drugs when used in people. FDA's March 2026 warning letters to sellers say so directly.
The prescription has to meet the standard of care: an evaluation, a medical indication, informed consent that covers the regulatory status and the evidence, and a monitoring plan.
The license has to match the patient's location. A physician licensed in one state who treats a patient located in another, including by telehealth, needs a license in the patient's state. The Interstate Medical Licensure Compact speeds that up in member states but still issues a separate license for each one.
Any kind. The doctors who prescribe peptides most often are endocrinologists (growth hormone and other approved peptide hormones), obesity medicine and primary care physicians (GLP-1 receptor agonists), and physicians in integrative, functional, sports, and longevity practices (compounded peptides). Board certification in a specialty shapes the standard of care a physician is held to. It adds no prescribing authority, and its absence takes none away.
Federal law has a provision aimed at a single peptide hormone. Under 21 U.S.C. 333(e), it is a felony to distribute human growth hormone, or possess it with intent to distribute, "for any use in humans other than the treatment of a disease or other recognized medical condition, where such use has been authorized by the Secretary of Health and Human Services under section 355 of this title and pursuant to the order of a physician."
Two consequences follow. Off-label growth hormone prescribing, which would be routine for most drugs, is a federal crime. And the statute speaks only of a physician's order. NPs and PAs who prescribe somatropin for an approved indication, such as adult growth hormone deficiency, should get a legal opinion on how that language applies to them before doing so. Several states also schedule growth hormone as a controlled substance under state law; Texas is one.
Growth hormone secretagogues are separate drugs and fall outside section 333(e).
Yes, in all 50 states, within the state's NP practice rules. Most peptides used clinically are not controlled substances, so the controlled substance limits that dominate NP scope debates, such as Schedule II restrictions and DEA registration, rarely apply to them. What matters is whether the state requires a physician agreement and, if so, whether that agreement covers peptides.
AANP sorts the states into three groups. In the 27 full practice states and DC, the NP prescribes under the authority of the board of nursing alone, though many of these states first require a transition period of supervised or collaborative practice, from 750 hours in Colorado to 3,600 hours in New York. The 12 reduced practice states require a career-long collaborative agreement with a physician for at least one element of practice, or limit the settings where an NP may practice. The 11 restricted practice states require career-long supervision, delegation, or team management by a physician.
In reduced and restricted states, the agreement is the document that decides whether an NP can prescribe peptides. Many agreements list drug categories or require protocols, and an agreement that leaves out compounded injectables or peptide therapy leaves the NP without authority to prescribe them. Our courses for nurses and nurse practitioners cover how to write peptide protocols into these agreements.
Each state links to AANP's fact sheet, and the last column gives the statute or rule it rests on. Rules change with each legislative session, so confirm with the state board of nursing before relying on any row.
| State | AANP 2026 | What an NP needs to prescribe peptides | Source |
|---|---|---|---|
| Alabama | Reduced | Collaborative agreement with a physician, regulated jointly by the Board of Nursing and Board of Medical Examiners | Ala. Code 34-21-90 |
| Alaska | Full | Prescribes independently | AS 08.68.850 |
| Arizona | Full | Prescribes independently | A.R.S. 32-1601 |
| Arkansas | Reduced | Collaborative practice agreement with a physician that covers prescribing | A.C.A. 17-87-310 |
| California | Restricted | Standardized procedures with a supervising physician and a furnishing number, or 103 or 104 NP status after a transition to practice | Bus. & Prof. Code 2836.1, 2837.103, 2837.104 |
| Colorado | Full | Independent after 750 hours in a mentorship with a physician or APRN | C.R.S. 12-255-112 |
| Connecticut | Full | Independent after three years and 2,000 hours in collaboration with a physician | C.G.S. 20-87a |
| Delaware | Full | Prescribes independently | 24 Del. C. 1902 |
| District of Columbia | Full | Prescribes independently | 17 DCMR 5999 |
| Florida | Restricted | Protocol with a supervising physician. Autonomous APRNs registered under section 464.0123 may practice without one in primary care only | Fla. Stat. 464.012 |
| Georgia | Restricted | Protocol agreement with a delegating physician | O.C.G.A. 43-34-25 |
| Hawaii | Full | Prescribes independently | HAR 16-89-2 |
| Idaho | Full | Prescribes independently | IDAPA 24.34.01.280 |
| Illinois | Reduced | Written collaborative agreement with a physician in many settings. NPs who complete the required practice hours and continuing education can qualify for full practice authority | 225 ILCS 65/65-43 |
| Indiana | Reduced | Collaborative agreement with a physician | IC 25-23-1-19.4 |
| Iowa | Full | Prescribes independently | Iowa Code 152.1 |
| Kansas | Full | Prescribes independently | K.S.A. 65-1130 |
| Kentucky | Reduced | Collaborative prescribing agreements with a physician unless the Board of Nursing grants an exemption after the required experience | KRS 314.042 |
| Louisiana | Reduced | Collaborative practice agreement with a physician | La. R.S. 37:913 |
| Maine | Full | Independent after 24 months under a supervising physician or NP, or in a clinic or hospital with a physician medical director | 32 M.R.S. 2102 |
| Maryland | Full | Independent after attesting to 18 months of mentorship with an NP or physician | Health Occ. 8-302.1 |
| Massachusetts | Full | Independent after two years with a supervising physician or APRN | M.G.L. ch. 112, 80E |
| Michigan | Restricted | Physician delegation is required for controlled substances. AANP lists no delegation requirement for non-controlled drugs, which covers most peptides | MCL 333.17212 |
| Minnesota | Full | Independent after 2,080 hours in a collaborative agreement | Minn. Stat. 148.211 |
| Mississippi | Reduced | Board-approved collaborative relationship with a physician or dentist | Miss. Code 73-15-20 |
| Missouri | Restricted | Career-long collaborative practice arrangement with a physician | RSMo 334.104, 335.175 |
| Montana | Full | Prescribes independently | ARM 24.159.1406 |
| Nebraska | Full | Independent after 2,000 hours under a supervising provider | Neb. Rev. Stat. 38-2314.01 |
| Nevada | Full | Prescribes independently. The experience requirement applies to Schedule II drugs only | NRS 632.237 |
| New Hampshire | Full | Prescribes independently | RSA 326-B:11 |
| New Jersey | Reduced | Joint protocols with a collaborating physician to prescribe drugs | N.J.S.A. 45:11-49 |
| New Mexico | Full | Prescribes independently | NMSA 61-3-23.2 |
| New York | Full | Independent after 3,600 hours. Before then, a written practice agreement and protocols with a collaborating physician | N.Y. Educ. Law 6902 |
| North Carolina | Restricted | Career-long collaborative practice agreement with a physician | 21 NCAC 36.0810 |
| North Dakota | Full | Prescribes independently | N.D. Admin. Code 54-05-03.1 |
| Ohio | Reduced | Standard care arrangement with a collaborating physician or podiatrist | R.C. 4723.43 |
| Oklahoma | Restricted | Physician supervision of prescriptive authority for the first 6,240 hours | 59 O.S. 567.4a |
| Oregon | Full | Prescribes independently | ORS 678.375 |
| Pennsylvania | Reduced | Prescriptive authority collaborative agreements with at least two physicians | 63 P.S. 212 |
| Rhode Island | Full | Prescribes independently | R.I. Gen. Laws 5-34-44 |
| South Carolina | Restricted | Practice agreement with a physician | S.C. Code 40-33-34 |
| South Dakota | Full | Independent after 1,040 hours under a collaborative agreement | SDCL 36-9A-4 |
| Tennessee | Restricted | Physician supervision, with formulary limits on Schedules II to IV | T.C.A. 63-7-123 |
| Texas | Restricted | Prescriptive authority agreement with a physician whose drug categories cover the prescription | Tex. Occ. Code 157.0512 |
| Utah | Full | Prescribes independently | Utah Code 58-31b-102 |
| Vermont | Full | Independent after 24 months and 2,400 hours. Before then, a collaborating agreement with a physician or APRN | 26 V.S.A. 1613 |
| Virginia | Restricted | Practice agreement with a patient care team physician, unless the NP attests to the equivalent of three years of full-time clinical experience | Va. Code 54.1-2957 |
| Washington | Full | Prescribes independently | RCW 18.79.250 |
| West Virginia | Reduced | Collaborative agreement with a physician for the first three years of prescribing | W. Va. Code 30-7-15b |
| Wisconsin | Reduced | Collaboration with a physician. Under the APRN Modernization Act, in effect since September 1, 2026, APRNs with 3,840 hours of RN practice and 3,840 hours of APRN practice may practice independently | Wis. Admin. Code N 8.10; 2025 Wis. Act 17 |
| Wyoming | Full | Prescribes independently | W.S. 33-21-120 |
An NP who treats patients in more than one state needs an NP license in each. The Nurse Licensure Compact covers RN licenses and does not extend NP prescribing across state lines.
Yes. Every state and the District of Columbia authorizes PAs to prescribe, and no state lets a PA practice without some agreement with a physician. The form of that agreement varies. Most states use a supervision or delegation agreement. A smaller group, including Iowa, Montana, New Hampshire, North Dakota, Utah, and Wyoming, has moved to collaboration or practice-level agreements that require less day-to-day oversight.
As with NPs in restricted states, the agreement decides the question for peptides. In Texas, for example, a PA prescribes under the same kind of prescriptive authority agreement as an NP, and it has to cover the drug categories prescribed. Our course for physician assistants covers building peptide protocols into practice agreements.
Naturopathic doctors. About two dozen states and DC license or register naturopathic doctors, and about 15 of them grant some prescriptive authority, according to a 2023 Connecticut legislative research survey. The scope runs from natural substances and a short list of legend drugs in some states to broad formularies, including injectables, in states such as Oregon, Washington, and Arizona. A naturopath considering peptides has to find them on the state's formulary, and many formularies will not cover compounded injectable peptides. In states that do not license naturopaths, they cannot prescribe at all.
Chiropractors. Chiropractors cannot prescribe drugs in nearly every state. New Mexico is the exception: certified advanced practice chiropractic physicians may prescribe and inject substances on a board-approved formulary, and drugs for injection outside the authorized list need approval from the state's Board of Pharmacy and Medical Board.
Pharmacists. Pharmacists dispense and compound peptides on a valid prescription, and a 503A pharmacy has to verify that the prescriber holds prescriptive authority in the state. Some states let pharmacists prescribe under protocols for defined drugs. A pharmacist cannot originate a peptide prescription unless a state protocol expressly covers that drug.
Registered nurses. RNs cannot prescribe. They can administer a peptide injection on the order of an authorized prescriber, which is how most clinic and med spa programs staff injections. An RN-owned clinic that offers peptides needs a physician, NP, or PA to evaluate each patient and issue the orders.
Medical assistants, estheticians, and coaches. None of these roles can prescribe. Whether a medical assistant may give an injection under supervision depends on state law, and estheticians may not give injections in any state that regulates them.
Peptides used as drugs have to be prescribed. That covers every FDA-approved peptide drug except a few, such as older human insulins, that are sold over the counter, and every compounded peptide, since a 503A pharmacy may compound only for an identified patient on a valid prescription. A 503B outsourcing facility may supply office stock to a clinic without a patient-specific prescription, but a licensed prescriber still has to order each use.
Two categories need no prescription because they are not drugs: collagen peptides sold as dietary supplements and taken by mouth, and topical peptides sold as cosmetics without drug claims. Research use only peptides sit outside every lawful pathway for human use, and a prescription cannot cure that. A clinician cannot prescribe them, and a patient who buys them has no assurance of identity, purity, or sterility.
No certification creates prescribing authority. Authority comes from a state license, and for NPs and PAs, from the agreements described above. A peptide certification or peptide CME course gives a licensed prescriber the clinical and regulatory knowledge to prescribe peptides to the standard of care: indications, dosing, monitoring, sourcing, and documentation. Medical boards judge a prescription against that standard, so documented training supports a clinician's position if a prescription is ever questioned.
Any program that suggests its certificate lets an unlicensed person prescribe, or lets an RN or esthetician run a peptide program without a prescriber, is misstating the law. Our comparison of peptide certification programs covers which ones carry accredited CME, and who can get Peptavo certified covers who our own certification is built for and how each profession claims its credit.
Run these checks for each new peptide program, in addition to the product checks in our US guide.
Yes. Any licensed MD or DO can prescribe FDA-approved peptide drugs, on or off label, and can order compounded peptides when the bulk substance and the pharmacy qualify under federal and state law. The exception is growth hormone, which federal law allows only for FDA-authorized conditions.
Physicians, nurse practitioners, and physician assistants prescribe nearly all peptides in the US. In some states, naturopathic doctors may prescribe peptides that appear on their formulary. Pharmacists fill and compound peptide prescriptions, and registered nurses administer them on a prescriber's order.
Yes, in every state. In 27 states and DC, NPs prescribe independently once they finish any required transition period. In the other 23 states, they prescribe under a collaborative agreement, protocol, or supervision arrangement with a physician, and that agreement has to cover peptides.
Any licensed physician, whatever the specialty. Endocrinologists, obesity medicine and primary care physicians, and physicians in integrative, sports, and longevity medicine prescribe them most often.
Yes, for any peptide used as a drug, whether FDA-approved or compounded, with a few over-the-counter exceptions such as older human insulins. Collagen supplements and cosmetic skin care peptides do not need one.
No. An RN can administer peptide injections on the order of a physician, NP, or PA, and cannot originate a prescription in any state.
Yes, when the telehealth evaluation meets the standard of care and the clinician is licensed in the patient's state. Most peptides are not controlled substances, so the federal Ryan Haight Act's in-person exam requirement does not apply to them. State telehealth rules still do.